Teva Sues BioMarin In UK Over Genetic Disorder Drug Patent
By Lucia Osborne-Crowley ( March 17, 2021, 6:23 PM GMT) -- Teva Pharmaceuticals has asked a London court to invalidate biotech firm BioMarin's U.K. patent on the world's only medical treatment for a rare inherited disorder affecting children as it seeks to make a generic version of the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.